Loading insider details...
Latest Form 4 (Apr 23, 2026): Disposition to Issuer of 72,292 DAWN shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Apr 23, 2026 | Day One Biopharmaceuticals, Inc. (DAWN) | Disposition to Issuer | 72,292 | n/a |
| Nov 7, 2025 | Day One Biopharmaceuticals, Inc. (DAWN) | Disposition to Issuer | 63,000 | n/a |
| Jun 4, 2025 | Day One Biopharmaceuticals, Inc. (DAWN) | Grant/Award | 22,500 | n/a |
| May 28, 2024 | Day One Biopharmaceuticals, Inc. (DAWN) | Grant/Award | 32,335 | n/a |
| Jun 26, 2023 | Day One Biopharmaceuticals, Inc. (DAWN) | Grant/Award | 37,500 | n/a |
| Jun 23, 2022 | Day One Biopharmaceuticals, Inc. (DAWN) | Grant/Award | 28,700 | n/a |
| Jun 2, 2021 | Day One Biopharmaceuticals, Inc. (DAWN) | Purchase | 7,000 | $112.0K |